CVS announces major breakup, pharmacy expert weighs impact on consumers

Key Points:

• CVS Health announced plans to split into two independent, publicly traded companies by the first half of 2028: one focusing on health insurance and pharmacy benefit management (including Aetna and CVS Caremark), and the other on retail pharmacy operations (including CVS Pharmacy and MinuteClinic).
• The breakup aims to enhance market competition, potentially lowering prescription drug costs and improving patient access, according to the National Community Pharmacists Association, which sees the move as beneficial to independent pharmacies.
• CVS shares fell nearly 13% following the announcement, reflecting investor concerns about the restructuring and its impact on the company's future performance.
• The split may help CVS unlock shareholder value by separating its slower-growing retail pharmacy business from its more profitable healthcare divisions, while also addressing regulatory scrutiny over vertical integration and conflicts of interest in pharmacy benefit management.
• Despite the separation, concerns remain about potential conflicts of interest, particularly as CVS Specialty will stay within the healthcare solutions division, maintaining control over lucrative specialty medication operations and patient steering practices.